For the year ending 2025-12-31, QNRX has $20,390,569 in assets. $7,270,663 in debts. $3,818,096 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 3,818,096 | |||
| Investments | 14,927,165 | |||
| Prepaid expenses and other current assets | 1,261,974 | |||
| Total current assets | 20,007,235 | |||
| Intangible assets, net | 383,334 | |||
| Total assets | 20,390,569 | |||
| Accounts payable | 1,262,222 | |||
| Accrued expenses | 2,538,457 | |||
| Accrued interest and financing expense | 1,146,251 | |||
| Due to officers - short term | 600,000 | |||
| Total current liabilities | 5,546,930 | |||
| Due to officers - long term | 1,723,733 | |||
| Total liabilities | 7,270,663 | |||
| Ordinary shares, no par value per share, 5,000,000,000 and 100,000,000 ordinary shares authorized at december 31, 2025 and december 31, 2024, respectively - 52,441,360 (1,498,325 ads's) ordinary shares issued and outstanding at december 31, 2025 and 8,948,164 (255,661 ads's) ordinary shares issued and outstanding at december 31, 2024 | 0 | |||
| Accumulated other comprehensive loss | -613 | |||
| Additional paid in capital | 84,090,966 | |||
| Accumulated deficit | -70,970,447 | |||
| Total shareholders' equity | 13,119,906 | |||
| Total liabilities and shareholders' equity | 20,390,569 | |||
Quoin Pharmaceuticals, Ltd. (QNRX)
Quoin Pharmaceuticals, Ltd. (QNRX)